Literature DB >> 15695371

Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells.

Dunyong Tan1, David A Johnson, Wei Wu, Lingfang Zeng, Yen Hao Chen, Wen Y Chen, Barbara K Vonderhaar, Ameae M Walker.   

Abstract

We have used bioluminescence resonance energy transfer (BRET) to examine the interaction between human prolactins (PRLs) and the long (LF) and two short isoforms (SF1a and SF1b) of the human PRL receptor in living cells. cDNA sequences encoding the LF, SF1a, and SF1b were subcloned into codon-humanized vectors containing cDNAs for either Renilla reniformis luciferase (Rluc) or a green fluorescent protein (GFP(2)) with a 12- or 13-amino acid linker connecting the parts of the fusion proteins. Transfection into human embryonic kidney 293 cells demonstrated maintained function of Rluc and GFP(2) when linked to the receptors, and confocal microscopy demonstrated the localization of tagged receptors in the plasma membrane by 48 h after transfection. All three tagged receptors transduced a signal, with the LF and SF1a stimulating, and SF1b inhibiting, promoter activity of an approximately 2.4-kb beta-casein-luc construct. Both unmodified PRL (U-PRL) and the molecular mimic of phosphorylated PRL, S179D PRL, induced BRET with all combinations of long and short receptor isoforms except SF1a plus SF1b. No BRET was observed with the site two-inactive mutant, G129R PRL. This is the first demonstration, 1) that species homologous PRL promotes both homo- and hetero-interaction of most long and short PRLR pairs in living cells, 2) that both U-PRL and S179D PRL are active in this regard, and 3) that there is some aspect of SF1a-SF1b structure that prevents this particular hetero-receptor pairing. In addition, we conclude that preferential pairing of different receptor isoforms is not the explanation for the different signaling initiated by U-PRL and S179D PRL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695371     DOI: 10.1210/me.2004-0304

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

Review 1.  Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

Authors:  KuangTzu Huang; Eric Ueda; YenHao Chen; Ameae M Walker
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

2.  An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.

Authors:  Dunyong Tan; KuanHui E Chen; Changhui Deng; Peizhi Tang; Jianjun Huang; Trina Mansour; Richard A Luben; Ameae M Walker
Journal:  Cancer Lett       Date:  2013-12-30       Impact factor: 8.679

3.  Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.

Authors:  John F Langenheim; Dunyong Tan; Ameae M Walker; Wen Y Chen
Journal:  Mol Endocrinol       Date:  2005-11-03

4.  Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis.

Authors:  Yasuhiro Terasaki; Kinnosuke Yahiro; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Mario P Stylianou; Jilly F Evans; Ameae M Walker; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

Review 5.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

Review 6.  Rational design of competitive prolactin/growth hormone receptor antagonists.

Authors:  Estelle Tallet; Vincent Rouet; Jean-Baptiste Jomain; Paul A Kelly; Sophie Bernichtein; Vincent Goffin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

7.  Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity.

Authors:  Kuang-tzu Huang; Ameae M Walker
Journal:  Prostate       Date:  2010-01-01       Impact factor: 4.104

8.  S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain.

Authors:  Dunyong Tan; Kuang Tzu Huang; Eric Ueda; Ameae M Walker
Journal:  Biochemistry       Date:  2007-12-15       Impact factor: 3.162

Review 9.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

10.  Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer.

Authors:  Estelle Tallet; Isabelle Fernandez; Chi Zhang; Marion Salsac; Nathalie Gregor; Mohammed Akli Ayoub; Jean Philippe Pin; Eric Trinquet; Vincent Goffin
Journal:  Front Endocrinol (Lausanne)       Date:  2011-09-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.